Sanli, N. M. Et Al. 2022. Long-term follow-up of ruxolitinib for therapy in corticosteroid refractory chronic graft-versus-host disease: A single center-experience. BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1 , 205.

Sanli, N. M., Karakus, E., Keklik, M., & Unal, A., (2022). Long-term follow-up of ruxolitinib for therapy in corticosteroid refractory chronic graft-versus-host disease: A single center-experience. BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, 205.

Sanli, N. Et Al. "Long-term follow-up of ruxolitinib for therapy in corticosteroid refractory chronic graft-versus-host disease: A single center-experience," BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, 205, 2022

Sanli, N. M. Et Al. "Long-term follow-up of ruxolitinib for therapy in corticosteroid refractory chronic graft-versus-host disease: A single center-experience." BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, pp.205, 2022

Sanli, N. M. Et Al. (2022) . "Long-term follow-up of ruxolitinib for therapy in corticosteroid refractory chronic graft-versus-host disease: A single center-experience." BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, p.205.

@article{article, author={N. Mandaci Sanli Et Al. }, title={Long-term follow-up of ruxolitinib for therapy in corticosteroid refractory chronic graft-versus-host disease: A single center-experience}, journal={BONE MARROW TRANSPLANTATION}, year=2022, pages={205} }